rebeccafrost, Author at ARC Group

News

UK confirmed to rejoin Horizon Europe

EPSILOGEN RESULTS PAVE THE WAY TO DEVELOPMENT OF NEW CLASS OF ANTI-CANCER DRUG

ARC takes finalist spot at Hustle Awards

A £650m funding package for the UK’s life sciences ecosystem welcomed by ARC

Ultromics granted FDA Breakthrough Device Designation

Biotech company Oxford BioDynamics awarded $963,000

OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth

you’ve seen 6 of 24 News

1
2
3
4